RXMD BILLION DOLLAR SUMMARY...
#1 - explanation of S1 status: 1 question only from SEC in the latest (3rd) round of back-and-forth
#2 - confirmation of uplist plan still in place: still the plan, still within 2021
#3 - update on uplist plan status and catalyst for proceeding: new investment banker that they believe will get the job done
#4 - management declared the diversification plan and strategy to be THE plan, after successful 340B contract services BETA project that yielded SUBSTANTIAL revenue ($1.4M over 1st 6 months of 2021) and 127% growth y-o-y.
#5 - management committed to plan for Nationwide Rollout of 340B Contract Services business in Q1 of 2022
#6 - management has made it a serious goal to be a $1B diversified healthcare technology services business within 5 years
#7 - Need access to capital that is non dilutive to finances future growth.
#8 - Five year plan to $1 billion through organic growth and acquisitions.
Just because you don’t like what someone says, doesn’t mean they’re wrong!